Fakhouri Abdulaziz S, Weist Jessica L, Tomusko Anthony R, Leight Jennifer L
1 Department of Biomedical Engineering, The Ohio State University, Columbus, Ohio.
2 The Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, Ohio.
Assay Drug Dev Technol. 2019 Apr;17(3):100-115. doi: 10.1089/adt.2018.877.
Three-dimensional (3D) cell culture systems more closely mimic the in vivo cellular microenvironment than traditional two-dimensional cell culture methods, making them a valuable tool in drug screening assays. However, 3D environments often make analysis of cellular responses more difficult, so most high-throughput (HT) 3D assays have been limited to measurements of cell viability. Yet, many other cell functions contribute to disease and are important pharmacological targets. Therefore, there is a need for new technologies that enable HT measurements of a wider range of cell functions for drug screening. Here, we have adapted a hydrogel system that enables cells to be cultured in a 3D environment and allows for the simultaneous detection of matrix metalloproteinase (MMP) and metabolic activities. This system was then characterized for utility in HT screening approaches. MMPs are critical regulators of tissue homeostasis and are upregulated in many diseases, such as arthritis and cancer. The developed assay achieved Z'-factor values above 0.9 and 0.5 for enzymatic and cellular assays, respectively, intraplate coefficients of variation (%CV) below 10% and 12%, respectively, and signal measurement was unaffected by dimethyl sulfoxide, a common solvent of therapeutic compounds. Human MMP-1, -2, and -9 resulted in a significant increase in signal intensity. Encapsulation of several cell types produced robust signals above background noise and within the linear range of the assay. Multiple drugs that are known to alter MMP activity were utilized in a range of concentrations with a fibrosarcoma cell line to demonstrate the feasibility of the assay for HT applications. This assay combines 3D cellular encapsulation and MMP activity detection in HT format, which makes it suitable for drug screening and development applications.
与传统的二维细胞培养方法相比,三维(3D)细胞培养系统更能紧密模拟体内细胞微环境,使其成为药物筛选试验中的一种有价值的工具。然而,3D环境通常会使细胞反应的分析更加困难,因此大多数高通量(HT)3D试验仅限于细胞活力的测量。然而,许多其他细胞功能与疾病相关且是重要的药理学靶点。因此,需要新技术来实现对更广泛细胞功能的HT测量以用于药物筛选。在这里,我们采用了一种水凝胶系统,该系统能够使细胞在3D环境中培养,并允许同时检测基质金属蛋白酶(MMP)和代谢活性。然后对该系统在HT筛选方法中的实用性进行了表征。MMP是组织稳态的关键调节因子,在许多疾病如关节炎和癌症中上调。所开发的试验在酶促和细胞试验中分别实现了Z'因子值高于0.9和0.5,板内变异系数(%CV)分别低于10%和12%,并且信号测量不受治疗性化合物的常见溶剂二甲基亚砜的影响。人MMP-1、-2和-9导致信号强度显著增加。几种细胞类型的封装产生了高于背景噪声且在试验线性范围内的稳健信号。使用一系列已知会改变MMP活性的药物,在一系列浓度下与纤维肉瘤细胞系一起使用,以证明该试验用于HT应用的可行性。该试验以HT形式结合了3D细胞封装和MMP活性检测,这使其适用于药物筛选和开发应用。